Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study to Determine the Negative Predictive Value of UroMark to Rule Out the Presence of Bladder Cancer in Patients With Haematuria.

NCT02676180 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02676180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02676180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study to Determine the Negative Predictive Value of UroMark to Rule Out the Presence of Bladder Cancer in Patients With Haematuria.
Lead sponsor
University College, London
Phase
Observational
Overall status
Completed
Start date
March 30, 2016
Completion date
December 31, 2017
Enrollment
3,700 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer